Home Overview Press Room Blog Publications For Students about us

Press Room : Displaying 63-72 of 93

California Enacts Law to Reduce Risks to Women Who Provide Eggs For Stem Cell ResearchSeptember 26th, 2006The signing of SB 1260, the Reproductive Health and Research bill, is a victory for women's health. The provisions of the new law will reduce the risks to women who provide eggs for cloning techniques used in stem cell research.
Gov. Schwarzenegger missed opportunity to establish oversight of California’s stem cell agencyJuly 20th, 2006Along with public funding should come public oversight. Instead, the Governor gave CIRM a blank check.
Passage Of Stem Cell Bill Spotlights Need For Federal OversightJuly 18th, 2006The lack of comprehensive federal oversight of stem cell research and other human biotechnologies has created a glaring regulatory vacuum.
A closer look at stem cell policy goes beyond the standard debatehttp://tcf.org/publications/pdfs/pb566/Stemcellbasics.pdfJune 27th, 2006Century Foundation and Center for Genetics and Society report sheds new light on stem cell policy
Public Interest Groups Call for "Needed Balance" on Stem Cell Research Oversight CommitteeMay 24th, 2006
Letter to National Academies Regarding Balance on Human Embryonic Stem Cell Research Advisory CommitteeMay 22nd, 2006
Proposed Policies for the California Stem Cell Program Leave GapsFebruary 9th, 2006
Public interest group gives the California Institute for Regenerative Medicine poor grades for its performanceThe Center for Genetics and Society releases progress report calling for effective oversight and responsible researchThe Center for Genetics and SocietyJanuary 18th, 2006The Center for Genetics and Society (CGS), a public interest and advocacy group, today released a comprehensive progress report critically evaluating the first year of the California Institute for Regenerative Medicine (CIRM), the agency running California's new multi-billion dollar stem cell research program. The report assesses the CIRM's performance, assigns grades in key areas, and offers specific policy recommendations. The overall grade it assigns for the CIRM's first year is C-.
Resignation of controversial Stem Cell leader highlights need for regulation and oversight of stem cell researchNovember 30th, 2005
California Stem Cell Research Leader Misled VotersNews reports say that chair of new state agency was aware of the billion-dollar problem during the campaignOctober 25th, 2005


home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760